医薬品企業の治験薬供給・ロジスティクス市場：2023-2033
Clinical Trial Supply and Logistics Market for Pharma 2023-2033
レポート詳細
医薬品企業の治験薬供給・ロジスティクス市場レポート 2023-2033 ： 本レポートは、新たな収益の柱を目指す大手企業にとって、業界とその根底にあるダイナミクスをより深く理解する上で... もっと見る
※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。
サマリー
レポート詳細
医薬品企業の治験薬供給・ロジスティクス市場レポート 2023-2033： 本レポートは、新たな収益の柱を目指す大手企業にとって、業界とその根底にあるダイナミクスをより深く理解する上で貴重なものとなるでしょう。異業種への進出や、新たな地域での既存事業の拡大を目指す企業にも有用です。
デジタル化、個別化医療、グローバリゼーションが医薬品企業の治験薬供給・ロジスティクスの状況を変える
医薬品企業の治験薬供給・ロジスティクスの状況は大きく変化している。デジタル化、個別化医療、グローバル化の流れは、企業が治験薬の管理と流通にどのように取り組むかを再構築しています。法規制の遵守と患者中心主義が最重要であることに変わりはありませんが、業界には、より俊敏で効率的なサプライチェーンオペレーションを実現するために先進技術を活用する機会が与えられています。サプライチェーンの複雑さ、不測の事態、コスト圧力に関連する課題を克服することは、この進化する状況をうまく乗り切ろうとする企業にとって極めて重要である。このようなトレンドを受け入れ、関連する機会を捉えることで、製薬企業は臨床試験サプライチェーンを最適化し、革新的な治療法をこれまで以上に効率的に患者に届けることができる。
3Dプリンティングとオンデマンド製造
3Dプリンティング技術の登場は、医薬品企業の治験薬供給・ロジスティクスに新たなフロンティアを開く。それは治験薬の製造と生産に革命をもたらす可能性を提供する。3Dプリンティングは、特定の医療機器、剤形、さらには個別化された治療法のオンデマンド・ローカライズ生産を可能にする。
このチャンスは、特殊な患者集団やニッチな患者集団を対象とする臨床試験にとって特に重要である。製薬会社は、中央集中型の製造施設や膨大なリードタイムに頼るのではなく、3Dプリンティングを使用して、治験実施施設の近くでカスタマイズされた治験薬を製造することができます。これにより、輸送や物流の複雑さが軽減されるだけでなく、より患者中心の臨床試験へのアプローチが可能になります。
さらに、3Dプリンティングは医療機器の迅速なプロトタイピングと反復を促進し、より効果的でカスタマイズされたソリューションの開発を可能にします。この技術により、研究者は臨床試験からの実際のフィードバックに基づいて製品を迅速に適応させ、改良することができ、最終的には、より革新的でインパクトのある治療法につながります。
市場調査レポートを購入する前にすべき質問とは？
- 医薬品企業の治験薬供給・ロジスティクス市場はどのように進化しているのか？
- 医薬品企業の治験薬供給・ロジスティクス市場の推進要因と阻害要因は何か？
- 医薬品企業の治験薬供給・ロジスティクスサブマーケットの各分野は予測期間中にどのように成長し、2033年にはどれくらいの売上を占めるようになるのか？
- 2023年から2033年にかけて、医薬品企業の治験薬供給・ロジスティクスサブマーケットごとの市場シェアはどのように推移するのか？
- 2023年から2033年にかけて、市場全体の主な牽引役は何か？
- 主要な医薬品企業の治験薬供給・ロジスティクス市場はマクロ経済の動きに概ね追随するのか、それとも各国市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどのように変化し、2033年に市場をリードするのはどの地域か？
- 主要プレイヤーは誰で、予測期間中の見通しは？
- これらの大手企業の医薬品プロジェクトの治験薬供給・ロジスティクスとは？
- 2023年から2033年にかけて、業界はどのように発展していくのか？現在および今後10年間に実施される医薬品企業の治験薬供給・ロジスティクスプロジェクトにはどのような影響がありますか？
- 医薬品企業の治験薬供給・ロジスティクス市場をさらに拡大するために、製品の商業化の必要性は高まっていますか？
- 医薬品企業の治験薬供給・ロジスティクス市場はどこに向かい、どのようにすれば市場の最前線に立てるのか？
- 新製品やサービスラインに対する最適な投資オプションは何か？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？
医薬品企業の治験薬供給・ロジスティクス市場が現在、そして今後10年間でどのような影響を受けるのかを知る必要があります：
- 本レポートは258ページにわたり、107の表と123の図表で構成されています。
- 本レポートでは、業界における主要な有利分野をハイライトしているため、今すぐターゲットを絞ることができます。
- 世界、地域、国の売上と成長に関する詳細な分析が含まれています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。
本レポートは、医薬品企業の治験薬供給・ロジスティクス市場が今後10年間にどのように発展するか、またCOVID-19の景気後退と回復の変動に合わせてどのように発展するかをお伝えします。この市場は、過去10年間のどの時点よりも今が重要である。
2033年までの予測やその他の分析から、商業的な展望が明らかになる
- 2033年までの収益予測に加え、直近の業績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望と展開に関する独自の分析をご覧いただけます。
- 定性的分析（市場ダイナミクス、促進要因、機会、阻害要因など）、ポーターのファイブフォース分析、PEST分析、最近の動向をご覧いただけます。
本レポートには、COVID-19が業界と貴社にどのような影響を与えるかについてのデータ分析と貴重な洞察が含まれている。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じている。
レポート対象セグメント
タイプ
- CTS製造
- CTS ロジスティクス＆ディストリビューション
- CT サプライチェーン管理
- CTS 包装・保管
フェーズ
- フェーズ I
- フェーズ II
- フェーズ III
- フェーズIV
- ローンチ後
世界市場全体と各分野の収益予測に加え、5つの地域と22の主要国市場の収益予測も掲載している：
北米
- アメリカ
- カナダ
欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- ロシア
- その他の欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- 東南アジア
- その他のアジア太平洋地域
ラテンアメリカ
- ブラジル
- メキシコ
- その他のラテンアメリカ
MEA
- GCC
- 南アフリカ
- その他のMEA
また、医薬品企業の治験薬供給・ロジスティクス市場の2023年から2033年にかけての主要企業のプロファイルも掲載しています。
報告書に掲載されている主要企業
・ Almac Group
・ Bilcare Limited
・ Biocair
・ Capsugel
・ Catalent, Inc.
・ Eurofins Scientific
・ FedEx
・ ICON plc
・ Intertek Group plc
・ KERRY LOGISTICS NETWORK LIMITED
・ Kuehne+Nagel
・ Marken (A UPS Company)
・ Mayne Pharma Group Limited
・ Movianto
・ Parexel International (MA) Corporation
・ PCI Pharma Services (PCI)
・ Thermo Fisher Scientific Inc.
・ United Parcel Service, Inc.
・ Yourway
医薬品企業の治験薬供給・ロジスティクス市場の2023年から2033年までの世界全体の売上高は、金額ベースでは2023年に130億米ドルを突破すると弊社では計算しています。2033年まで力強い収益成長を予測しています。当社の調査では、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進捗状況、商業的見通しを知ることで、一歩先を行くことができます。
2023年から2033年までの製薬会社向け治験薬供給・ロジスティクス市場に関する報告書はどのようにお役に立ちますか？
まとめると、250ページを超えるこのレポートは、以下のような知識を提供する：
- 医薬品企業の治験薬供給・ロジスティクス市場の2023年から2033年までの収益予測、タイプ別・フェーズ別予測、世界レベル・地域レベルの各予測 - 業界の将来性を発見し、投資と収益に最も有利な場所を見つけます。
- 5つの地域と22の主要国市場の2033年までの収益予測 - 医薬品企業の治験薬供給・ロジスティクス市場の2023年から2033年までの北米、欧州、アジア太平洋、ラテンアメリカ、MEAの市場予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの著名経済圏の市場も予測しています。
- 既存企業および市場参入を目指す企業の展望 - 医薬品企業の治験薬供給・ロジスティクス市場に関わる主要企業19社の企業プロファイルを含む、2023年から2033年までの市場。
独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を得ることができます。
他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性が低くなります。Visiongainの調査レポートが貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの調査は、医薬品企業の治験薬供給・ロジスティクス市場2023年から2033年、市場をリードする企業の商業的分析を必要とするすべての人のためのものです。データ、トレンド、予測をご覧いただけます。
ページTOPに戻る
目次
目次
1 レポートの概要
1.1 調査の目的
1.2 医薬品企業の治験薬供給・ロジスティクス市場の紹介
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問は以下の通り：
1.6 本レポートは誰のためのものか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データ検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ）
1.9 Visiongainの関連レポート
1.10 Visiongainについて
2 エグゼクティブ・サマリー
3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.2.1 市場促進要因
3.2.1.1 治験の分散化／バーチャル化の動き
3.2.1.2 アジア太平洋諸国における臨床試験実施の可能性の増加
3.2.1.3 臨床試験量の増加
3.2.2 市場抑制要因
3.2.2.1 臨床試験および医療コールドチェーン物流
3.2.2.2 輸送における人為的または自然的混乱
3.2.2.3 高い財務コスト
3.2.3 市場機会
3.2.3.1 AIと機械学習はより多くのデータとともに進化する
3.2.3.2 バーチャル治験とテクノロジーが患者や施設に受け入れられつつある
3.2.3.3 大企業が市場を牽引している
3.3 COVID-19インパクト分析
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤーの力
3.4.2 買い手の力
3.4.3 競争ライバル
3.4.4 代替品による脅威
3.4.5 新規参入企業の脅威
3.5 PEST分析
4 医薬企業の治験薬供給・ロジスティクス市場分析：タイプ別
4.1 主要な調査結果
4.2 タイプ別セグメント 市場魅力度指数
4.3 医薬品企業の治験薬供給・ロジスティクスタイプ別市場規模の推定と予測
4.4 CTS製造
4.4.1 2023〜2033年の地域別市場予測（US$ Billion, AGR %)
4.4.2 2023年・2033年の地域別市場シェア(%)
4.5 CTS物流・流通
4.5.1 2023～2033年の地域別市場予測（US$ Billion, AGR %)
4.5.2 2023年および2033年の地域別市場シェア(%)
4.6 CTサプライチェーン管理
4.6.1 2023～2033年の地域別市場予測（US$ Billion, AGR %)
4.6.2 2023年および2033年の地域別市場シェア(%)
4.7 CTSパッケージング＆ストレージ
4.7.1 2023～2033年の地域別市場予測（US$ Billion, AGR %)
4.7.2 地域別市場シェア、2023年・2033年(%)
5 医薬企業の治験薬供給・ロジスティクス市場分析：フェーズ別
5.1 主要な調査結果
5.2 フェーズセグメント 市場魅力度指数
5.3 医薬品企業の治験薬供給・ロジスティクス：フェーズ別市場規模の推定と予測
5.4 前臨床
5.4.1 2023〜2033年の地域別市場予測（US$ Billion, AGR %)
5.4.2 2023年・2033年の地域別市場シェア(%)
5.5 フェーズI
5.5.1 2023〜2033年の地域別市場予測（US$ Billion, AGR %)
5.5.2 2023年および2033年の地域別市場シェア(%)
5.6 フェーズII
5.6.1 2023〜2033年の地域別市場予測（US$ Billion, AGR %)
5.6.2 地域別市場シェア、2023年＆2033年(%)
5.7 フェーズ III
5.7.1 2023〜2033年の地域別市場予測（US$ Billion, AGR %)
5.7.2 地域別市場シェア、2023年＆2033年(%)
5.8 第Ⅳ相
5.8.1 2023〜2033年の地域別市場予測（US$ Billion, AGR %)
5.8.2 2023年および2033年の地域別市場シェア(%)
5.9 ローンチ後
5.9.1 2023〜2033年の地域別市場予測（US$ Billion, AGR %)
5.9.2 2023年および2033年の地域別市場シェア(%)
6 医薬企業の治験薬供給・ロジスティクス市場分析：地域別
6.1 主要な調査結果
6.2 地域別市場規模の推定と予測
7 北米の医薬品企業の治験薬供給・ロジスティクス市場分析
7.1 主要な調査結果
7.2 北米の医薬品企業の治験薬供給・ロジスティクス市場の魅力度指数
7.3 北米の医薬品企業の治験薬供給・ロジスティクス市場の国別市場規模、2023年、2028年、2033年（US$ Billion）
7.4 北米の医薬品企業の治験薬供給・ロジスティクス市場規模推定と予測：国別
7.5 北米の医薬品企業の治験薬供給・ロジスティクス市場規模推定と予測：タイプ別
7.6 北米の医薬品企業の治験薬供給・ロジスティクス市場規模推定と予測：フェーズ別
7.7 北米の医薬品企業の治験薬供給・ロジスティクス市場分析
7.8 カナダの医薬品企業の治験薬供給・ロジスティクス市場分析
8 欧州の医薬品企業の治験薬供給・ロジスティクス市場分析
8.1 主要な調査結果
8.2 欧州の医薬品企業の治験薬供給・ロジスティクス市場の魅力度指数
8.3 欧州の医薬品企業の治験薬供給・ロジスティクス市場の国別市場規模、2023年、2028年、2033年（US$ Billion）
8.4 欧州の医薬品企業の治験薬供給・ロジスティクス市場規模推定と予測：国別
8.5 欧州の医薬品企業の治験薬供給・ロジスティクス市場規模推定と予測：タイプ別
8.6 欧州の医薬品企業の治験薬供給・ロジスティクス市場規模推定と予測：フェーズ別
8.7 ドイツの医薬品企業の治験薬供給・ロジスティクス市場分析
8.8 イギリスの医薬品企業の治験薬供給・ロジスティクス市場分析
8.9 フランスの医薬品企業の治験薬供給・ロジスティクス市場分析
8.10 イタリアの医薬企業の治験薬供給・ロジスティクス市場分析
8.11 スペインの医薬品企業の治験薬供給・ロジスティクス市場分析
8.12 ロシアの医薬品企業の治験薬供給・ロジスティクス市場分析
8.13 その他の欧州の医薬品企業の治験薬供給・ロジスティクス市場分析
9 アジア太平洋地域の医薬品企業の治験薬供給・ロジスティクス市場分析
9.1 主要な調査結果
9.2 アジア太平洋地域の医薬品企業の治験薬供給・ロジスティクス市場魅力度指数
9.3 アジア太平洋地域の医薬品企業の治験薬供給・ロジスティクス市場の国別市場規模、2023年、2028年、2033年（US$ Billion）
9.4 アジア太平洋地域の医薬品企業の治験薬供給・ロジスティクス市場規模推定と予測：国別
9.5 アジア太平洋地域の医薬品企業の治験薬供給・ロジスティクス市場規模推定と予測：タイプ別予
9.6 アジア太平洋地域の医薬品企業の治験薬供給・ロジスティクス市場規模推定と予測：フェーズ別
9.7 日本の医薬品企業の治験薬供給・ロジスティクス市場分析
9.8 中国の医薬企業の治験薬供給・ロジスティクス市場分析
9.9 インドの医薬品企業の治験薬供給・ロジスティクス市場分析
9.10 オーストラリアの医薬品企業の治験薬供給・ロジスティクス市場分析
9.11 韓国の医薬品企業の治験薬供給・ロジスティクス市場分析
9.12 東南アジアの医薬品企業の治験薬供給・ロジスティクス市場分析
9.13 その他のアジア太平洋地域の医薬品企業の治験薬供給・ロジスティクス市場分析
10 ラテンアメリカの医薬品企業の治験薬供給・ロジスティクス市場分析
10.1 主要な調査結果
10.2 ラテンアメリカの医薬品企業の治験薬供給・ロジスティクス市場の魅力度指数
10.3 ラテンアメリカの医薬品企業の治験薬供給・ロジスティクス国別市場、2023年、2028年、2033年 (US$ Billion)
10.4 ラテンアメリカの医薬品企業の治験薬供給・ロジスティクス市場規模推定と予測：国別
10.5 ラテンアメリカの医薬品企業の治験薬供給・ロジスティクス市場規模推定と予測：タイプ別
10.6 ラテンアメリカの医薬品企業の治験薬供給・ロジスティクス市場規模推定と予測：フェーズ別
10.7 ブラジルの医薬品企業の治験薬供給・ロジスティクス市場分析
10.8 メキシコの医薬品企業の治験薬供給・ロジスティクス市場分析
10.9 その他のラテンアメリカ地域の医薬品企業の治験薬供給・ロジスティクス市場分析
11 MEAの医薬品企業の治験薬供給・ロジスティクス市場分析
11.1 主要な調査結果
11.2 MEAの医薬品企業の治験薬供給・ロジスティクス市場魅力度指数
11.3 MEAの医薬品企業の治験薬供給・ロジスティクス国別市場、2023年、2028年、2033年 (US$ Billion)
11.4 MEAの医薬品企業の治験薬供給・ロジスティクス市場規模推定と予測：国別
11.5 MEAの医薬品企業の治験薬供給・ロジスティクス市場規模推定と予測：タイプ別
11.6 MEAの医薬品企業の治験薬供給・ロジスティクス市場規模推定と予測：フェーズ別
11.7 GCCの医薬品企業の治験薬供給・ロジスティクス市場分析
11.8 南アフリカの医薬品企業の治験薬供給・ロジスティクス市場分析
11.9 MEAの医薬品企業の治験薬供給・ロジスティクス市場分析
12 企業のプロフィール
12.1 Catalent, Inc.
12.1.1 会社概要
12.1.2 会社概要
12.1.3 財務分析
12.1.3.1 純収入、2018-2022年
12.1.3.2 地域市場シェア、2022年
12.1.4 製品ベンチマーク
12.1.5 戦略的展望
12.2 Thermo Fisher Scientific Inc.
12.2.1 会社概要
12.2.2 会社概要
12.2.3 財務分析
12.2.3.1 純収入、2018-2022年
12.2.3.2 R＆D、2015-2022年
12.2.3.3 地域市場シェア、2022年
12.2.4 製品ベンチマーク
12.2.5 戦略的展望
12.2.6 戦略的展望
12.3 ICON plc
12.3.1 会社概要
12.3.2 会社概要
12.3.3 財務分析
12.3.3.1 売上高、2018年～2022年
12.3.3.2 地域市場シェア、2022年
12.3.4 製品ベンチマーク
12.3.5 戦略的展望
12.4 Eurofins Scientific
12.4.1 会社概要
12.4.2 会社概要
12.4.3 財務分析
12.4.3.1 純収入、2018-2022年
12.4.3.2 地域市場シェア、2022年
12.4.4 提供サービス
12.4.5 戦略的展望
12.5 FedEx
12.5.1 会社概要
12.5.2 会社概要
12.5.3 財務分析
12.5.3.1 純収入、2015年～2022年
12.5.3.2 地域別市場シェア、2022年
12.5.4 製品ベンチマーク
12.5.5 戦略的展望
12.6 United Parcel Service, Inc.
12.6.1 会社概要
12.6.2 会社概要
12.6.3 財務分析
12.6.3.1 純収入、2018-2022年
12.6.4 製品ベンチマーク
12.7 KERRY LOGISTICS NETWORK LIMITED
12.7.1 会社概要
12.7.2 会社概要
12.7.3 財務分析
12.7.3.1 純収入、2017-2021年
12.7.3.2 地域市場シェア、2022年
12.7.4 製品ベンチマーク
12.8 Kuehne+Nagel
12.8.1 会社概要
12.8.2 会社概要
12.8.3 財務分析
12.8.3.1 純収入、2018年〜2022年
12.8.3.2 地域市場シェア、2022年
12.8.4 製品ベンチマーク
12.8.5 戦略的展望
12.9 Bilcare Limited
12.9.1 会社概要
12.9.2 会社概要
12.9.3 財務分析
12.9.3.1 純収入、2018-2022年
12.9.3.2 地域市場シェア、2022年
12.9.4 製品ベンチマーク
12.10 Mayne Pharma Group Limited
12.10.1 会社概要
12.10.2 会社概要
12.10.3 財務分析
12.10.3.1 純収入、2018-2022年
12.10.3.2 地域市場シェア、2022年
12.10.4 製品ベンチマーク
12.10.5 戦略的展望
12.11 Intertek Group plc
12.11.1 会社概要
12.11.2 会社概要
12.11.3 財務分析
12.11.3.1 純収入、2017-2021年
12.11.4 製品ベンチマーク
12.11.5 戦略的展望
12.12 Almac Group
12.12.1 会社概要
12.12.2 会社概要
12.12.3 製品ベンチマーク
12.12.4 戦略的展望
12.13 Parexel International (MA) Corporation
12.13.1 会社概要
12.13.2 会社概要
12.13.3 製品ベンチマーク
12.13.4 戦略的展望
12.14 Biocair
12.14.1 会社概要
12.14.2 会社概要
12.14.3 製品ベンチマーク
12.14.4 戦略的展望
12.15 Marken (A UPS Company)
12.15.1 会社概要
12.15.2 会社概要
12.15.3 製品ベンチマーク
12.15.4 戦略的展望
12.16 PCI Pharma Services (PCI)
12.16.1 会社概要
12.16.2 会社概要
12.16.3 製品ベンチマーク
12.16.4 戦略的展望
12.17 Capsugel
12.17.1 会社概要
12.17.2 会社概要
12.17.3 製品ベンチマーク
12.17.4 戦略的展望
12.18 Movianto
12.18.1 会社概要
12.18.2 会社概要
12.18.3 製品ベンチマーク
12.19 Yourway
12.19.1 会社概要
12.19.2 会社概要
12.19.3 製品ベンチマーク
13 結論と提言
13.1 Visiongainからの結びの言葉
13.2 市場プレイヤーへの提言
ページTOPに戻る
図表リスト
表の一覧
Table 1 Clinical Trial Supply and Logistics for Pharma Market Snapshot, 2023 & 2033 (US$ billion, CAGR %)
Table 2 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 7 CTS Manufacturing Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 8 CTS Logistics & Distribution Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 9 CT Supply Chain Management Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 10 CTS Packaging & Storage Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 11 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 12 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 13 Phase I Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 14 Phase II Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 15 Phase III Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 16 Phase IV Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 17 Post Launch Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 18 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 19 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 20 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 21 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 22 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 23 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 24 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 25 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 26 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 27 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 28 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 29 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 30 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 31 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 32 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 33 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 34 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 35 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 36 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 37 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 38 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 39 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 40 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 41 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 42 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 43 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 44 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 45 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 46 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 47 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 48 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 49 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 50 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 51 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 52 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 53 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 54 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 55 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 56 Catalent, Inc.: Product Benchmarking
Table 57 Catalent, Inc.: Strategic Outlook
Table 58 Thermo Fisher Scientific Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 59 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 60 Thermo Fisher Scientific Inc.: Recent Developments
Table 61 UDG Healthcare Plc: Recent Developments
Table 62 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 ICON plc: Product Benchmarking
Table 64 ICON plc: Recent Developments
Table 65 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 66 Eurofins Scientific: Services Offered
Table 67 Eurofins Scientific: Strategic Outlook
Table 68 FedEx: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 FedEx: Product Benchmarking
Table 70 FedEx: Strategic Outlook
Table 71 United Parcel Service, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 United Parcel Service, Inc.: Product Benchmarking
Table 73 KERRY LOGISTICS NETWORK LIMITED: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 KERRY LOGISTICS NETWORK LIMITED: Product Benchmarking
Table 75 Kuehne+Nagel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Kuehne+Nagel: Product Benchmarking
Table 77 Kuehne+Nagel: Strategic Outlook
Table 78 Bilcare Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Bilcare Limited: Product Benchmarking
Table 80 Mayne Pharma Group Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Mayne Pharma Group Limited: Product Benchmarking
Table 82 Mayne Pharma Group Limited: Recent Developments
Table 83 Intertek Group plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Intertek Group plc: Product Benchmarking
Table 85 Intertek Group plc: Recent Developments
Table 86 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Almac Group: Product Benchmarking
Table 88 Almac Group: Recent Developments
Table 89 Parexel International (MA) Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Parexel International (MA) Corporation: Product Benchmarking
Table 91 Parexel International (MA) Corporation: Recent Developments
Table 92 Biocair: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Biocair: Product Benchmarking
Table 94 Biocair: Strategic Outlook
Table 95 Marken (A UPS Company): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Marken (A UPS Company): Product Benchmarking
Table 97 Marken (A UPS Company): Strategic Outlook
Table 98 PCI Pharma Services (PCI): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 PCI Pharma Services (PCI): Product Benchmarking
Table 100 PCI Pharma Services (PCI): Recent Developments
Table 101 Capsugel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Capsugel: Product Benchmarking
Table 103 Capsugel: Recent Developments
Table 104 Movianto: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Movianto: Product Benchmarking
Table 106 Yourway: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Yourway: Product Benchmarking
図の一覧
Figure 1 Clinical Trial Supply and Logistics for Pharma Market Segmentation
Figure 2 Clinical Trial Supply and Logistics for Pharma Market by Type: Market Attractiveness Index
Figure 3 Clinical Trial Supply and Logistics for Pharma Market by Phase: Market Attractiveness Index
Figure 4 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Region
Figure 5 Global Clinical Trials Supply and Logistics Market: Market Dynamics
Figure 6 Clinical Trial Supply and Logistics for Pharma Market by Region, 2023-2033 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 7 Clinical Trial Supply and Logistics for Pharma Market by Region, 2023-2033 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 8 Clinical Trial Supply and Logistics for Pharma Market by Region, 2023-2033 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 9 Clinical Trial Supply and Logistics for Pharma Market by Region, 2023-2033 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 10 Clinical Trial Supply and Logistics for Pharma Market: Porter’s Five Forces Analysis
Figure 11 Clinical Trial Supply and Logistics for Pharma Market: PEST Analysis
Figure 12 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
Figure 13 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 14 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023, 2028, 2033 (%)
Figure 15 CTS Manufacturing Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 16 CTS Manufacturing Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 17 CTS Logistics & Distribution Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 18 CTS Logistics & Distribution Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 CT Supply Chain Management Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 20 CT Supply Chain Management Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 CTS Packaging & Storage Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 22 CTS Packaging & Storage Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
Figure 24 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 25 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023, 2028, 2033 (%)
Figure 26 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 27 Preclinical Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Phase I Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 29 Phase I Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Phase II Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 31 Phase II Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Phase III Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 33 Phase III Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Phase IV Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 35 Phase IV Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Post Launch Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 37 Post Launch Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 39 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 40 Clinical Trial Supply and Logistics for Pharma Market by Region, 2023-2033 (US$ Mn)
Figure 41 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 42 North America Clinical Trial Supply and Logistics for Pharma Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 43 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ billion)
Figure 44 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2023 & 2033 (%)
Figure 45 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 46 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023 & 2033 (%)
Figure 47 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 48 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 49 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 50 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 51 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 52 Europe Clinical Trial Supply and Logistics for Pharma Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 53 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ billion)
Figure 54 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2023 & 2033 (%)
Figure 55 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 56 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023 & 2033 (%)
Figure 57 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 58 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 59 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 60 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 61 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 62 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 63 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 64 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 65 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 66 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 67 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 68 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ billion)
Figure 69 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2023 & 2033 (%)
Figure 70 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 71 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023 & 2033 (%)
Figure 72 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 73 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 74 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 75 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 76 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 77 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 78 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 79 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 80 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 81 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 82 Latin America Clinical Trial Supply and Logistics for Pharma Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 83 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ billion)
Figure 84 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2023 & 2033 (%)
Figure 85 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 86 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023 & 2033 (%)
Figure 87 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 88 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 89 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 90 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 91 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 92 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 93 MEA Clinical Trial Supply and Logistics for Pharma Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 94 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ billion)
Figure 95 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2023 & 2033 (%)
Figure 96 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 97 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023 & 2033 (%)
Figure 98 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 99 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 100 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 101 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 102 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 103 Catalent, Inc.: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 104 Catalent, Inc.: Regional Market Shares, 2022
Figure 105 Thermo Fisher Scientific Inc: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 106 Thermo Fisher Scientific Inc: R&D, 2018-2022 (US$ Million, AGR%)
Figure 107 Thermo Fisher Scientific Inc: Regional Market Shares, 2022
Figure 108 ICON plc: Revenue, 2018-2022 (US$ Million, AGR%)
Figure 109 ICON plc: Regional Market Shares, 2022
Figure 110 Eurofins Scientific: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 111 Eurofins Scientific: Regional Market Shares, 2022
Figure 112 FedEx: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 113 FedEx: Regional Market Shares, 2022
Figure 114 United Parcel Service, Inc.: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 115 KERRY LOGISTICS NETWORK LIMITED: Net Revenue, 2017-2021 (US$million, AGR %)
Figure 116 KERRY LOGISTICS NETWORK LIMITED: Regional Market Shares, 2022
Figure 117 Kuehne+Nagel: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 118 Kuehne+Nagel: Regional Market Shares, 2022
Figure 119 Bilcare Limited: Net Revenue, 2018-2022 (US$million, AGR %)
Figure 120 Bilcare Limited: Regional Market Shares, 2022
Figure 121 Mayne Pharma Group Limited: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 122 Mayne Pharma Group Limited: Regional Market Shares, 2022
Figure 123 Intertek Group plc: Net Revenue, 2017-2021 (US$ Million, AGR %)
ページTOPに戻る
Summary
Report Details
The Clinical Trial Supply and Logistics for Pharma Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Digitization, Personalized Medicine, and Globalization Reshaping Clinical Trials Supply Logistics Landscape
The landscape of clinical trial supply logistics in the pharmaceutical industry is undergoing a significant transformation. The trends towards digitization, personalized medicine, and globalization are reshaping how companies approach the management and distribution of investigational products. While regulatory compliance and patient-centricity remain paramount, the industry is presented with opportunities to leverage advanced technologies for more agile and efficient supply chain operations. Overcoming challenges associated with supply chain complexity, unforeseen events, and cost pressures will be critical for companies seeking to navigate this evolving landscape successfully. By embracing these trends and seizing the associated opportunities, pharmaceutical companies can optimize their clinical trial supply chains to deliver innovative therapies to patients more efficiently than ever before.
3D Printing and On-Demand Manufacturing
The advent of 3D printing technology opens up a new frontier in clinical trial supply logistics. It offers the potential to revolutionize the manufacturing and production of investigational products. 3D printing allows for on-demand, localized production of certain medical devices, dosage forms, and even personalized treatments.
This opportunity is particularly significant for trials involving specialized or niche patient populations. Rather than relying on centralized manufacturing facilities and extensive lead times, pharmaceutical companies can use 3D printing to produce customized investigational products closer to the trial sites. This not only reduces transportation and logistics complexities but also enables a more patient-centric approach to clinical trials.
Furthermore, 3D printing can facilitate rapid prototyping and iteration of medical devices, allowing for the development of more effective and tailored solutions. This technology empowers researchers to quickly adapt and refine their products based on real-world feedback from clinical trials, ultimately leading to more innovative and impactful therapies.
What Questions Should You Ask before Buying a Market Research Report?
• How is the clinical trial supply and logistics for pharma market evolving?
• What is driving and restraining the clinical trial supply and logistics for pharma market?
• How will each clinical trial supply and logistics for pharma submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each clinical trial supply and logistics for pharma submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading clinical trial supply and logistics for pharma markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the clinical trial supply and logistics for pharma projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of
clinical trial supply and logistics for pharma projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the clinical trial supply and logistics for pharma market?
• Where is the clinical trial supply and logistics for pharma market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the clinical trial supply and logistics for pharma market today, and over the next 10 years:
• Our 258-page report provides 107 tables and 123 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the clinical trial supply and logistics for pharma market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Type
• CTS Manufacturing
• CTS Logistics & Distribution
• CT Supply Chain Management
• CTS Packaging & Storage
Phase
• Phase I
• Phase II
• Phase III
• Phase IV
• Post Launch
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• South-East Asia
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Clinical Trial Supply and Logistics for Pharma Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies profiled in the report
• Almac Group
• Bilcare Limited
• Biocair
• Capsugel
• Catalent, Inc.
• Eurofins Scientific
• FedEx
• ICON plc
• Intertek Group plc
• KERRY LOGISTICS NETWORK LIMITED
• Kuehne+Nagel
• Marken (A UPS Company)
• Mayne Pharma Group Limited
• Movianto
• Parexel International (MA) Corporation
• PCI Pharma Services (PCI)
• Thermo Fisher Scientific Inc.
• United Parcel Service, Inc.
• Yourway
Overall world revenue for Clinical Trial Supply and Logistics for Pharma Market, 2023 to 2033 in terms of value the market will surpass US$13 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Clinical Trial Supply and Logistics for Pharma Market, 2023 to 2033 report help you?
In summary, our 250+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Clinical Trial Supply and Logistics for Pharma Market 2023 to 2033, with forecasts for type and phase, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 22 key national markets – See forecasts for the Clinical Trial Supply and Logistics for Pharma Market, 2023 to 2033 market in North America, Europe, Asia Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 19 of the major companies involved in the Clinical Trial Supply and Logistics for Pharma Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Clinical Trial Supply and Logistics for Pharma Market 2023 to 2033, market-leading companies. You will find data, trends and predictions.
ページTOPに戻る
Table of Contents
Table of Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Clinical Trial Supply and Logistics for Pharma Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Move Towards Decentralized/Virtual Trials
3.2.1.2 Increasing Possibilities for Conducting Clinical Trials in Asia Pacific Nations
3.2.1.3 Growing Clinical Trials Volume
3.2.2 Market Restraining Factors
3.2.2.1 Clinical Trial and Medical Cold Chain Logistics
3.2.2.2 Man-made or Natural Disruption in Transportation
3.2.2.3 High Financial Cost
3.2.3 Market Opportunities
3.2.3.1 AI and Machine Learning are Evolving with More Data
3.2.3.2 Virtual Trials and Technology Are Gaining Acceptance among Patients and Sites
3.2.3.3 Big Companies are driving the Market
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Clinical Trial Supply and Logistics for Pharma Market Analysis by Type
4.1 Key Findings
4.2 Type Segment: Market Attractiveness Index
4.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
4.4 CTS Manufacturing
4.4.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 CTS Logistics & Distribution
4.5.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 CT Supply Chain Management
4.6.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 CTS Packaging & Storage
4.7.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
4.7.2 Market Share by Region, 2023 & 2033 (%)
5 Clinical Trial Supply and Logistics for Pharma Market Analysis by Phase
5.1 Key Findings
5.2 Phase Segment: Market Attractiveness Index
5.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
5.4 Preclinical
5.4.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Phase I
5.5.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Phase II
5.6.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Phase III
5.7.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Phase IV
5.8.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 Post Launch
5.9.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.9.2 Market Share by Region, 2023 & 2033 (%)
6 Clinical Trial Supply and Logistics for Pharma Market Analysis by Region
6.1 Key Findings
6.2 Regional Market Size Estimation and Forecast
7 North America Clinical Trial Supply and Logistics for Pharma Market Analysis
7.1 Key Findings
7.2 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
7.3 North America Clinical Trial Supply and Logistics for Pharma Market by Country, 2023, 2028 & 2033 (US$ Billion)
7.4 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
7.5 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
7.6 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
7.7 U.S. Clinical Trial Supply and Logistics for Pharma Market Analysis
7.8 Canada Clinical Trial Supply and Logistics for Pharma Market Analysis
8 Europe Clinical Trial Supply and Logistics for Pharma Market Analysis
8.1 Key Findings
8.2 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
8.3 Europe Clinical Trial Supply and Logistics for Pharma Market by Country, 2023, 2028 & 2033 (US$ Billion)
8.4 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
8.5 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
8.6 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
8.7 Germany Clinical Trial Supply and Logistics for Pharma Market Analysis
8.8 UK Clinical Trial Supply and Logistics for Pharma Market Analysis
8.9 France Clinical Trial Supply and Logistics for Pharma Market Analysis
8.10 Italy Clinical Trial Supply and Logistics for Pharma Market Analysis
8.11 Spain Clinical Trial Supply and Logistics for Pharma Market Analysis
8.12 Russia Clinical Trial Supply and Logistics for Pharma Market Analysis
8.13 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Analysis
9 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis
9.1 Key Findings
9.2 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
9.3 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Country, 2023, 2028 & 2033 (US$ Billion)
9.4 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
9.5 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
9.6 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
9.7 Japan Clinical Trial Supply and Logistics for Pharma Market Analysis
9.8 China Clinical Trial Supply and Logistics for Pharma Market Analysis
9.9 India Clinical Trial Supply and Logistics for Pharma Market Analysis
9.10 Australia Clinical Trial Supply and Logistics for Pharma Market Analysis
9.11 South Korea Clinical Trial Supply and Logistics for Pharma Market Analysis
9.12 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Analysis
9.13 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis
10 Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis
10.1 Key Findings
10.2 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
10.3 Latin America Clinical Trial Supply and Logistics for Pharma Market by Country, 2023, 2028 & 2033 (US$ Billion)
10.4 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
10.5 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
10.6 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
10.7 Brazil Clinical Trial Supply and Logistics for Pharma Market Analysis
10.8 Mexico Clinical Trial Supply and Logistics for Pharma Market Analysis
10.9 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis
11 MEA Clinical Trial Supply and Logistics for Pharma Market Analysis
11.1 Key Findings
11.2 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
11.3 MEA Clinical Trial Supply and Logistics for Pharma Market by Country, 2023, 2028 & 2033 (US$ Billion)
11.4 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
11.5 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
11.6 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
11.7 GCC Clinical Trial Supply and Logistics for Pharma Market Analysis
11.8 South Africa Clinical Trial Supply and Logistics for Pharma Market Analysis
11.9 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Analysis
12 Company Profiles
12.1 Catalent, Inc.
12.1.1 Company Snapshot
12.1.2 Company Overview
12.1.3 Financial Analysis
12.1.3.1 Net Revenue, 2018-2022
12.1.3.2 Regional Market Shares, 2022
12.1.4 Product Benchmarking
12.1.5 Strategic Outlook
12.2 Thermo Fisher Scientific Inc.
12.2.1 Company Snapshot
12.2.2 Company Overview
12.2.3 Financial Analysis
12.2.3.1 Net Revenue, 2018-2022
12.2.3.2 R&D, 2015-2022
12.2.3.3 Regional Market Shares, 2022
12.2.4 Product Benchmarking
12.2.5 Strategic Outlook
12.2.6 Strategic Outlook
12.3 ICON plc
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Financial Analysis
12.3.3.1 Revenue, 2018-2022
12.3.3.2 Regional Market Shares, 2022
12.3.4 Product Benchmarking
12.3.5 Strategic Outlook
12.4 Eurofins Scientific
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Financial Analysis
12.4.3.1 Net Revenue, 2018-2022
12.4.3.2 Regional Market Shares, 2022
12.4.4 Services Offered
12.4.5 Strategic Outlook
12.5 FedEx
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Financial Analysis
12.5.3.1 Net Revenue, 2015-2022
12.5.3.2 Regional Market Shares, 2022
12.5.4 Product Benchmarking
12.5.5 Strategic Outlook
12.6 United Parcel Service, Inc.
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Financial Analysis
12.6.3.1 Net Revenue, 2018-2022
12.6.4 Product Benchmarking
12.7 KERRY LOGISTICS NETWORK LIMITED
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Financial Analysis
12.7.3.1 Net Revenue, 2017-2021
12.7.3.2 Regional Market Shares, 2022
12.7.4 Product Benchmarking
12.8 Kuehne+Nagel
12.8.1 Company Snapshot
12.8.2 Company Overview
12.8.3 Financial Analysis
12.8.3.1 Net Revenue, 2018-2022
12.8.3.2 Regional Market Shares, 2022
12.8.4 Product Benchmarking
12.8.5 Strategic Outlook
12.9 Bilcare Limited
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Financial Analysis
12.9.3.1 Net Revenue, 2018-2022
12.9.3.2 Regional Market Shares, 2022
12.9.4 Product Benchmarking
12.10 Mayne Pharma Group Limited
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Financial Analysis
12.10.3.1 Net Revenue, 2018-2022
12.10.3.2 Regional Market Shares, 2022
12.10.4 Product Benchmarking
12.10.5 Strategic Outlook
12.11 Intertek Group plc
12.11.1 Company Snapshot
12.11.2 Company Overview
12.11.3 Financial Analysis
12.11.3.1 Net Revenue, 2017-2021
12.11.4 Product Benchmarking
12.11.5 Strategic Outlook
12.12 Almac Group
12.12.1 Company Snapshot
12.12.2 Company Overview
12.12.3 Product Benchmarking
12.12.4 Strategic Outlook
12.13 Parexel International (MA) Corporation
12.13.1 Company Snapshot
12.13.2 Company Overview
12.13.3 Product Benchmarking
12.13.4 Strategic Outlook
12.14 Biocair
12.14.1 Company Snapshot
12.14.2 Company Overview
12.14.3 Product Benchmarking
12.14.4 Strategic Outlook
12.15 Marken (A UPS Company)
12.15.1 Company Snapshot
12.15.2 Company Overview
12.15.3 Product Benchmarking
12.15.4 Strategic Outlook
12.16 PCI Pharma Services (PCI)
12.16.1 Company Snapshot
12.16.2 Company Overview
12.16.3 Product Benchmarking
12.16.4 Strategic Outlook
12.17 Capsugel
12.17.1 Company Snapshot
12.17.2 Company Overview
12.17.3 Product Benchmarking
12.17.4 Strategic Outlook
12.18 Movianto
12.18.1 Company Snapshot
12.18.2 Company Overview
12.18.3 Product Benchmarking
12.19 Yourway
12.19.1 Company Snapshot
12.19.2 Company Overview
12.19.3 Product Benchmarking
13 Conclusion and Recommendations
13.1 Concluding Remarks from Visiongain
13.2 Recommendations for Market Players
ページTOPに戻る
List of Tables/Graphs
List of Tables
Table 1 Clinical Trial Supply and Logistics for Pharma Market Snapshot, 2023 & 2033 (US$ billion, CAGR %)
Table 2 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 7 CTS Manufacturing Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 8 CTS Logistics & Distribution Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 9 CT Supply Chain Management Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 10 CTS Packaging & Storage Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 11 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 12 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 13 Phase I Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 14 Phase II Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 15 Phase III Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 16 Phase IV Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 17 Post Launch Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 18 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 19 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 20 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 21 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 22 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 23 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 24 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 25 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 26 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 27 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 28 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 29 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 30 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 31 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 32 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 33 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 34 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 35 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 36 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 37 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 38 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 39 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 40 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 41 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 42 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 43 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 44 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 45 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 46 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 47 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 48 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 49 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 50 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 51 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 52 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 53 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 54 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 55 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 56 Catalent, Inc.: Product Benchmarking
Table 57 Catalent, Inc.: Strategic Outlook
Table 58 Thermo Fisher Scientific Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 59 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 60 Thermo Fisher Scientific Inc.: Recent Developments
Table 61 UDG Healthcare Plc: Recent Developments
Table 62 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 ICON plc: Product Benchmarking
Table 64 ICON plc: Recent Developments
Table 65 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 66 Eurofins Scientific: Services Offered
Table 67 Eurofins Scientific: Strategic Outlook
Table 68 FedEx: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 FedEx: Product Benchmarking
Table 70 FedEx: Strategic Outlook
Table 71 United Parcel Service, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 United Parcel Service, Inc.: Product Benchmarking
Table 73 KERRY LOGISTICS NETWORK LIMITED: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 KERRY LOGISTICS NETWORK LIMITED: Product Benchmarking
Table 75 Kuehne+Nagel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Kuehne+Nagel: Product Benchmarking
Table 77 Kuehne+Nagel: Strategic Outlook
Table 78 Bilcare Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Bilcare Limited: Product Benchmarking
Table 80 Mayne Pharma Group Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Mayne Pharma Group Limited: Product Benchmarking
Table 82 Mayne Pharma Group Limited: Recent Developments
Table 83 Intertek Group plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Intertek Group plc: Product Benchmarking
Table 85 Intertek Group plc: Recent Developments
Table 86 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Almac Group: Product Benchmarking
Table 88 Almac Group: Recent Developments
Table 89 Parexel International (MA) Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Parexel International (MA) Corporation: Product Benchmarking
Table 91 Parexel International (MA) Corporation: Recent Developments
Table 92 Biocair: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Biocair: Product Benchmarking
Table 94 Biocair: Strategic Outlook
Table 95 Marken (A UPS Company): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Marken (A UPS Company): Product Benchmarking
Table 97 Marken (A UPS Company): Strategic Outlook
Table 98 PCI Pharma Services (PCI): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 PCI Pharma Services (PCI): Product Benchmarking
Table 100 PCI Pharma Services (PCI): Recent Developments
Table 101 Capsugel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Capsugel: Product Benchmarking
Table 103 Capsugel: Recent Developments
Table 104 Movianto: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Movianto: Product Benchmarking
Table 106 Yourway: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Yourway: Product Benchmarking
List of Figures
Figure 1 Clinical Trial Supply and Logistics for Pharma Market Segmentation
Figure 2 Clinical Trial Supply and Logistics for Pharma Market by Type: Market Attractiveness Index
Figure 3 Clinical Trial Supply and Logistics for Pharma Market by Phase: Market Attractiveness Index
Figure 4 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Region
Figure 5 Global Clinical Trials Supply and Logistics Market: Market Dynamics
Figure 6 Clinical Trial Supply and Logistics for Pharma Market by Region, 2023-2033 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 7 Clinical Trial Supply and Logistics for Pharma Market by Region, 2023-2033 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 8 Clinical Trial Supply and Logistics for Pharma Market by Region, 2023-2033 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 9 Clinical Trial Supply and Logistics for Pharma Market by Region, 2023-2033 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 10 Clinical Trial Supply and Logistics for Pharma Market: Porter’s Five Forces Analysis
Figure 11 Clinical Trial Supply and Logistics for Pharma Market: PEST Analysis
Figure 12 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
Figure 13 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 14 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023, 2028, 2033 (%)
Figure 15 CTS Manufacturing Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 16 CTS Manufacturing Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 17 CTS Logistics & Distribution Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 18 CTS Logistics & Distribution Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 CT Supply Chain Management Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 20 CT Supply Chain Management Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 CTS Packaging & Storage Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 22 CTS Packaging & Storage Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
Figure 24 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 25 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023, 2028, 2033 (%)
Figure 26 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 27 Preclinical Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Phase I Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 29 Phase I Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Phase II Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 31 Phase II Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Phase III Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 33 Phase III Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Phase IV Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 35 Phase IV Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Post Launch Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 37 Post Launch Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 39 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 40 Clinical Trial Supply and Logistics for Pharma Market by Region, 2023-2033 (US$ Mn)
Figure 41 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 42 North America Clinical Trial Supply and Logistics for Pharma Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 43 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ billion)
Figure 44 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2023 & 2033 (%)
Figure 45 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 46 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023 & 2033 (%)
Figure 47 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 48 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 49 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 50 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 51 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 52 Europe Clinical Trial Supply and Logistics for Pharma Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 53 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ billion)
Figure 54 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2023 & 2033 (%)
Figure 55 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 56 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023 & 2033 (%)
Figure 57 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 58 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 59 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 60 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 61 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 62 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 63 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 64 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 65 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 66 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 67 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 68 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ billion)
Figure 69 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2023 & 2033 (%)
Figure 70 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 71 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023 & 2033 (%)
Figure 72 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 73 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 74 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 75 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 76 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 77 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 78 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 79 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 80 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 81 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 82 Latin America Clinical Trial Supply and Logistics for Pharma Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 83 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ billion)
Figure 84 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2023 & 2033 (%)
Figure 85 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 86 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023 & 2033 (%)
Figure 87 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 88 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 89 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 90 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 91 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 92 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 93 MEA Clinical Trial Supply and Logistics for Pharma Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 94 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ billion)
Figure 95 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2023 & 2033 (%)
Figure 96 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 97 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023 & 2033 (%)
Figure 98 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 99 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 100 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 101 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 102 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 103 Catalent, Inc.: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 104 Catalent, Inc.: Regional Market Shares, 2022
Figure 105 Thermo Fisher Scientific Inc: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 106 Thermo Fisher Scientific Inc: R&D, 2018-2022 (US$ Million, AGR%)
Figure 107 Thermo Fisher Scientific Inc: Regional Market Shares, 2022
Figure 108 ICON plc: Revenue, 2018-2022 (US$ Million, AGR%)
Figure 109 ICON plc: Regional Market Shares, 2022
Figure 110 Eurofins Scientific: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 111 Eurofins Scientific: Regional Market Shares, 2022
Figure 112 FedEx: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 113 FedEx: Regional Market Shares, 2022
Figure 114 United Parcel Service, Inc.: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 115 KERRY LOGISTICS NETWORK LIMITED: Net Revenue, 2017-2021 (US$million, AGR %)
Figure 116 KERRY LOGISTICS NETWORK LIMITED: Regional Market Shares, 2022
Figure 117 Kuehne+Nagel: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 118 Kuehne+Nagel: Regional Market Shares, 2022
Figure 119 Bilcare Limited: Net Revenue, 2018-2022 (US$million, AGR %)
Figure 120 Bilcare Limited: Regional Market Shares, 2022
Figure 121 Mayne Pharma Group Limited: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 122 Mayne Pharma Group Limited: Regional Market Shares, 2022
Figure 123 Intertek Group plc: Net Revenue, 2017-2021 (US$ Million, AGR %)
ページTOPに戻る
Visiongain社の医薬・化学品分野での最新刊レポート
本レポートと同じKEY WORD（logistics market）の最新刊レポート
よくあるご質問
Visiongain社はどのような調査会社ですか?
英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
